Skip to main content
Log in

Kombinierte Behandlung eines kutanen Non-Hodgkin-Lymphoms mit Rituximab und Polychemotherapie

  • Kurzkasuistiken
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Armitage JO, Fyfe MA, Lewis J (1984) Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen. J Clin Oncol 2: 898–902

    PubMed  Google Scholar 

  2. Buske C, Dreyling M, Unterhalt M, Hiddemann W (2004) Monoclonal antibody treatment of malignant lymphoma. Internist 45: 1370–1377

    Article  PubMed  Google Scholar 

  3. Harris NL, Jaffe ES, Stein H et al. (1994) A revised european-american classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84: 1361–1392

    PubMed  Google Scholar 

  4. Trümper L, Möller P, Neubauer A (2001) Non-Hodgkin-Lymphome. In: Hiddemann W, Bartram C, Huber H (Hrsg) Lehrbuch der Klinischen Onkologie. Springer, Berlin Heidelberg New York, S 24–27

Download references

Interessenkonflikt

Keine Angaben.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K.-W. Schulte.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reinerth, G., Bruch-Gerharz, D., Kruse, R. et al. Kombinierte Behandlung eines kutanen Non-Hodgkin-Lymphoms mit Rituximab und Polychemotherapie. Hautarzt 58, 295–297 (2007). https://doi.org/10.1007/s00105-007-1314-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-007-1314-0

Navigation